242 related articles for article (PubMed ID: 22658687)
1. Perioperative use of levosimendan: best practice in operative settings.
Toller W; Algotsson L; Guarracino F; Hörmann C; Knotzer J; Lehmann A; Rajek A; Salmenperä M; Schirmer U; Tritapepe L; Weis F; Landoni G
J Cardiothorac Vasc Anesth; 2013 Apr; 27(2):361-6. PubMed ID: 22658687
[No Abstract] [Full Text] [Related]
2. [LEVOSIMENDAN--THE FIRST 10 YEARS IN CLINICAL PRACTICE].
Rybka MM; Lobacheva GV
Anesteziol Reanimatol; 2015; 60(5):80-4. PubMed ID: 26852586
[TBL] [Abstract][Full Text] [Related]
3. Levosimendan versus an intra-aortic balloon pump in adult cardiac surgery patients with low cardiac output.
Elahi MM; Lam J; Asopa S; Matata BM
J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):1154-62. PubMed ID: 21376634
[No Abstract] [Full Text] [Related]
4. Levosimendan for Hemodynamic Support after Cardiac Surgery.
Landoni G; Lomivorotov VV; Alvaro G; Lobreglio R; Pisano A; Guarracino F; Calabrò MG; Grigoryev EV; Likhvantsev VV; Salgado-Filho MF; Bianchi A; Pasyuga VV; Baiocchi M; Pappalardo F; Monaco F; Boboshko VA; Abubakirov MN; Amantea B; Lembo R; Brazzi L; Verniero L; Bertini P; Scandroglio AM; Bove T; Belletti A; Michienzi MG; Shukevich DL; Zabelina TS; Bellomo R; Zangrillo A;
N Engl J Med; 2017 May; 376(21):2021-2031. PubMed ID: 28320259
[TBL] [Abstract][Full Text] [Related]
5. Levosimendan: a new option in acute cardiac failure.
Holley AD; Ziegenfuss M
Emerg Med Australas; 2006; 18(5-6):505-9. PubMed ID: 17083641
[No Abstract] [Full Text] [Related]
6. The vasoactive-inotropic score and levosimendan: time for LVIS?
Favia I; Vitale V; Ricci Z
J Cardiothorac Vasc Anesth; 2013 Apr; 27(2):e15-6. PubMed ID: 23507021
[No Abstract] [Full Text] [Related]
7. Levosimendan in patients with low-output heart failure: lessons from the LIDO trial.
Follath F
Ital Heart J; 2003 May; 4 Suppl 2():34S-38S. PubMed ID: 14635368
[TBL] [Abstract][Full Text] [Related]
8. Oral levosimendan in patients with severe chronic heart failure --the PERSIST study.
Nieminen MS; Cleland JG; Eha J; Belenkov Y; Kivikko M; Põder P; Sarapohja T
Eur J Heart Fail; 2008 Dec; 10(12):1246-54. PubMed ID: 18945637
[TBL] [Abstract][Full Text] [Related]
9. Levosimendan.
Mason P
Intensive Crit Care Nurs; 2003 Dec; 19(6):370-1. PubMed ID: 14637297
[No Abstract] [Full Text] [Related]
10. Cost-benefits of incorporating levosimendan into cardiac surgery practice: German base case.
Mardiguian S; Kivikko M; Heringlake M; Smare C; Bertranou E; Apajasalo M; Pollesello P
J Med Econ; 2016; 19(5):506-14. PubMed ID: 26707159
[TBL] [Abstract][Full Text] [Related]
11. [Levosimendan. Clinical indications of a new vasoactive substance].
Braun JP; Döpfmer U; Kastrup M; Roots I; Borges A; Schneider M; Dohmen P; Kox W; Spies C
Anaesthesist; 2004 Feb; 53(2):163-7. PubMed ID: 14991194
[TBL] [Abstract][Full Text] [Related]
12. Effect of levosimendan on survival and adverse events after cardiac surgery: a meta-analysis.
Harrison RW; Hasselblad V; Mehta RH; Levin R; Harrington RA; Alexander JH
J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):1224-32. PubMed ID: 24050857
[TBL] [Abstract][Full Text] [Related]
13. [Intensive care for newborns and babies of the first year of life with acute heart failure after cardiosurgical interventions].
Lobacheva GV; Khar'kin AV; Manerova AF; Dzhobava ER
Anesteziol Reanimatol; 2010; (5):23-7. PubMed ID: 21400728
[TBL] [Abstract][Full Text] [Related]
14. Management of acute cardiac failure by intracoronary administration of levosimendan.
Caimmi PP; Kapetanakis EI; Beggino C; Molinari C; Giustini G; Crosio E; Reposo G; Micalizzi E; Vacca G; Grossini E
J Cardiovasc Pharmacol; 2011 Sep; 58(3):246-53. PubMed ID: 21654504
[TBL] [Abstract][Full Text] [Related]
15. Useful supplement to the best practice of using levosimendan in cardiac surgery patients: 2.5-mg intravenous bolus for cardiopulmonary resuscitation during perioperative cardiac arrest.
Carev M; Karanovic N; Kocen D; Bulat C
J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):e75-7. PubMed ID: 24267577
[No Abstract] [Full Text] [Related]
16. Levosimendan for the treatment of acute heart failure syndromes: time to identify subpopulations of responding patients.
Parissis JT; Farmakis D; Bistola V; Adamopoulos S; Kremastinos DT
Am J Cardiol; 2007 Jan; 99(1):146-7. PubMed ID: 17196480
[No Abstract] [Full Text] [Related]
17. Levosimendan compared with dobutamine in low output patients.
Nieminen MS
Minerva Anestesiol; 2003 Apr; 69(4):258-63. PubMed ID: 12766717
[TBL] [Abstract][Full Text] [Related]
18. [Role of Levosimendan in intensive care treatment of myocardial insufficiency].
Rehberg S; Ertmer C; Van Aken H; Lange M; Bröking K; Morelli A; Westphal M
Anaesthesist; 2007 Jan; 56(1):30-43. PubMed ID: 17131137
[TBL] [Abstract][Full Text] [Related]
19. Levosimendan for low cardiac output: a pediatric experience.
Egan JR; Clarke AJ; Williams S; Cole AD; Ayer J; Jacobe S; Chard RB; Winlaw DS
J Intensive Care Med; 2006; 21(3):183-7. PubMed ID: 16672640
[TBL] [Abstract][Full Text] [Related]
20. Reply to Carev et al: "Useful supplement to the best practice of using levosimendan in cardiac surgery patients: 2.5 mg intravenous bolus for cardiopulmonary resuscitation during perioperative cardiac arrest".
Toller W; Guarracino F; Landoni G
J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):e77-8. PubMed ID: 24267578
[No Abstract] [Full Text] [Related]
[Next] [New Search]
